Quest Diagnostics Incorporated
US ˙ NYSE ˙ US74834L1008

SecurityDGX / Quest Diagnostics Incorporated
InstitutionBartlett & Co. LLC
Latest Disclosed Ownership109 shares
Latest Disclosed Value $ 15
Bartlett & Co. LLC ownership in DGX / Quest Diagnostics Incorporated

On January 8, 2024 - Bartlett & Co. LLC filed a 13F-HR form disclosing ownership of 109 shares of Quest Diagnostics Incorporated (US:DGX) valued at $15,029 USD as of December 31, 2023. The entity filed a previous 13F-HR on October 10, 2023 disclosing 109 shares of Quest Diagnostics Incorporated. The current value of the position is $21,832 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-01-08 2023-12-31 13F Quest Diagnostic COM 74834L100 109 0 0.00 0 0.0002
2023-10-10 2023-09-30 13F Quest Diagnostic COM 74834L100 109 -200 -64.72 0 0.0002
2023-07-14 2023-06-30 13F Quest Diagnostic COM 74834L100 309 0 0.00 0 0.0007
2023-04-06 2023-03-31 13F Quest Diagnostic COM 74834L100 309 0 0.00 0 -100.00 0.0008
2023-01-04 2022-12-31 13F Quest Diagnostic COM 74834L100 309 0 0.00 0 -100.00 0.0010
2022-10-17 2022-09-30 13F Quest Diagnostic COM 74834L100 309 -10 -3.13 38 -9.52 0.0008
2022-08-02 2022-06-30 13F Quest Diagnostic COM 74834L100 319 10 3.24 42 0.00 0.0009
2022-05-13 2022-03-31 13F Quest Diagnostic COM 74834L100 309 309 42 0.0007
2022-03-08 2021-12-31 13F Quest Diagnostics COM 74834L100 0 -409 -100.00 0 -100.00
2021-10-15 2021-09-30 13F Quest Diagnostics COM 74834L100 409 -6 -1.45 59 7.27 0.0011
2021-07-19 2021-06-30 13F Quest Diagnostics COM 74834L100 415 0 0.00 55 3.77 0.0010
2021-04-19 2021-03-31 13F Quest Diagnostics COM 74834L100 415 -200 -32.52 53 -27.40 0.0011
2021-01-20 2020-12-31 13F Quest Diagnostics COM 74834L100 615 6 0.99 73 4.29 0.0016
2020-10-20 2020-09-30 13F Quest Diagnostics COM 74834L100 609 0 0.00 70 1.45 0.0016
2020-08-03 2020-06-30 13F Quest Diagnostics COM 74834L100 609 0 0.00 69 40.82 0.0018
2020-05-07 2020-03-31 13F Quest Diagnostics COM 74834L100 609 500 458.72 49 308.33 0.0015
2019-11-04 2019-09-30 13F Quest Diagnostics COM 74834L100 109 109 12 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.